- Lobbying
- Lindsey AND Trischler
Lobbying Arrangements Results for 'Lindsey Trischler'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details Treatment for Parkinson's Disease |
Pike Therapeutics
Pharmaceutical company |
iPolicy Solutions | |||
Details Scalability of regenerative medicine technology |
Cellino Biotech Inc.
|
iPolicy Solutions | |||
Details Rare Disease Center of Excellence |
EveryLife Foundation for Rare Diseases
Advocacy organization for patients with rare diseases |
iPolicy Solutions | |||
Details companion diagnostics at FDA, no bill # Verifying Accurate Leading-Edge IVCT Development (VALID) Act, coverage and reimbursement of molecular diagnostics. |
Mount Sinai Genomics, Inc. (d/b/a Sema4)
|
CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | |||
Details Clinical Laboratory Fee Schedule Contract Year 2025 Policy and Technical Changes to the Medicare Advantage Program (CMS-4205-P) |
Guardant Health Inc.
|
iPolicy Solutions | |||
Details Cancer Moonshot Patient Access to lab results FY 2018 Labor, Health and Human Services, Education and related agencies Appropriations Act |
Cure Forward
|
CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | |||
Details Reimbursement of diagnostics FY 2019 Labor, Health and Human Services and Education Appropriations bill, S. 3158 |
Invitae, Inc.
|
CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | |||
Details FY 2019, Labor, Health and Human Services and Education Appropriations Act Health Disparities |
Counsyl
|
CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | |||
Details FY24 and FY25 Labor, Health and Human Services Appropriations bill |
COOLEY'S ANEMIA FOUNDATION
|
CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | |||
Details No bill #: Labor, Health and Human Services, Education and Related Agencies Appropriations bill S. 2333: Pandemic All Hazards Preparedness Authorization Act H.R.4702/S.2400 - Securing Gene Synthes... |
Twist Bioscience Corporation
|
iPolicy Solutions | |||
Details Real World Evidence Patient Reported Outcomes Medical Product Communications Act of 2017, HR 1703 Prescription Drug Price Transparency Act, HR 1316 Drug Pricing Biosimilars Patient Right to Know Dr... |
Global Healthy Living Foundation
|
CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | |||
Details FY 2023 Appropriations for LHHS and DoD |
Lupus Research Alliance
|
CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | |||
Details Cancer research funding-Labor HHS bill S. 2039, Cancer Drug Parity Act, HELP Copays Act Defense Appropriations: CDMRP (advocate for blood cancer research funding) |
International Myeloma Foundation
|
in-house lobbying | |||
Details CHF works to educate, advocate and build awareness for public health funding |
Coalition for Health Funding
|
CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | |||
Details S 1000/HR 2377, Saving Access to Laboratory Services Act |
Association for Molecular Pathology
|
CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | |||
Details Direct to consumer genetic testing No bill number, Consumer Genetic Data Privacy Act of 2022 H.R. 8152, the American Data Privacy and Protection Act |
23andMe, Inc.
|
iPolicy Solutions | |||
Details No bill #: legislation to modernize CLIA H.R.2369 - VALID Act of 2023 FDA Proposed Rulemaking on LDTs S.2140: Patent Eligibility Restoration Act of 2023 |
Association for Molecular Pathology
|
iPolicy Solutions | |||
Details S. 2039//H.R. 6301, the Cancer Drug Parity Act; Cancer Moonshot FY24 Labor Health Human Services and Related Agencies |
International Myeloma Foundation
|
CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | |||
Details FY2021, Labor, HHS and Education Appropriations bill Funding for DOD breast cancer research program HR 2428, S 3216 ABCD Act Implementation of Affordable Care Act Surprise Medical Billing Public an... |
Susan G. Komen
|
CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | |||
Details FY25 Appropriations for the prevention of child sexual assault at CDC |
Johns Hopkins University Moore Center for the Prevention of Child Sexual Abuse
conducts research to help prevent child sexual abuse through a public health model |
CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | |||
Details H.R.2369 - VALID Act of 2023 FDA Proposed rule on LDTs No bill #: Precision Medicine Access for Kids Today Act H.R.1526: Reducing Hereditary Cancer Act S.2140: Patent Eligibility Restoration Act No... |
Invitae Inc.
|
iPolicy Solutions |